How big is the amniotic membrane market?

Posted 2023-05-15 17:41:58

According to the latest report by IMARC Group, titled “Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global amniotic membrane market reached a value of US$ 1,290 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,220 Million by 2027, exhibiting a CAGR of 9.4% during 2022-2027.

Industry Overview and Application:

The amniotic membrane (AM) refers to the innermost layer of the placenta that comprises of an epithelial monolayer, acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity, which is filled with amniotic liquid and assists in healing wounds and protecting against infection. Amniotic membranes have various properties, such as anti-inflammatory, anti-bacterial, anti-viral, immunological, anti-angiogenic, proapoptotic, etc. As they interfere with tumor growth by preventing the delivery of nutrients and oxygen to cancer cells, AMs also find various applications in the field of oncology.

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/amniotic-membrane-market/requestsample

The growing number of corneal surgeries due to their ability to reduce pain, improve the appearance of a diseased or damaged cornea, restore vision, etc., represents one of the key factors driving the amniotic membrane market. AMs also assist in enhancing epithelialization, maintaining epithelial phenotype, reinforcing adhesion of basal epithelial cells, etc. Furthermore, AMs are relatively cost-effective as compared to allografts and xenografts and find extensive applications in cosmetic and reconstructive surgeries. Additionally, the increasing investments in research and development (R&D) activities in the field of stem cell and regenerative are also augmenting the market growth. Besides this, rising placenta donations and the escalating demand for tissue-based products for treating surgical wounds will continue to bolster the amniotic membrane market.

Amniotic Membrane Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the global amniotic membrane market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Amnio Technology LLC
Amniox Medical Inc. (TissueTech Inc.)
Genesis Biologics
Human Regenerative Technologies LLC
Integra LifeSciences Holdings Corporation
Katena Products Inc.
MiMedx Group
Next Biosciences
Skye Biologics Holdings LLC
Smith & Nephew plc
Surgenex LLC
Ventris Medical LLC
Wright Medical Group N.V. (Stryker B.V.)

Key Market Segmentation:

The report has segmented the global amniotic membrane market on the basis of product, application, end user and region.

Breakup by Product:

Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane

Breakup by Application:

Surgical Wounds
Ophthalmology
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Research Centers and Laboratory

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Explore Full Report Description At: https://www.imarcgroup.com/amniotic-membrane-market

Key Highlights of the Report:

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

LinkedIn: https://www.linkedin.com/company/imarc-group